focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 23.00
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 3.00 (13.043%)
Open: 24.50
High: 0.00
Low: 0.00
Prev. Close: 24.50
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: SkinBio launches food supplement on Amazon

Thu, 30th Nov 2023 14:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Iofina PLC - Colorado, US-based manufacturing company that specialises in the production of iodine and the manufacture of speciality chemical derivatives - Reminds investors that the ramp-up of IO9, its iodine plant in Western Oklahoma, took longer than expected. Says that recent upgrades have improved the flow of brine water to the plant, adding that it has been able to steadily increase crystalline iodine production following the completion of this work. Confirms that the plant is now operating within its expected output range. Expects second-half production at the bottom, or very marginally below, the bottom end of the forecast range of 325 to 350 metric tonnes.

----------

SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Says that its AxisBiotix-Ps food supplement will launch on Amazon.co.uk from December 6. AxisBiotix-Ps is designed to help alleviate sensitive skin conditions like psoriasis. SkinBio Therapeutics says the sale of the product on Amazon is a key part of its commercialisation strategy, and that it aims to extend product availability through other Amazon country sites. Says management is already proactively seeking to expand online sales of AxisBiotix-Ps into France, Italy, and Spain, where the product has regulatory clearance.

----------

Oncimmune Holdings PLC - Nottingham, England-based immunodiagnostics developer - Notes strategic progress towards end of first quarter, including contracts signed for four new projects, with additional contracts approved by customers and due to be signed in the second quarter. Says three of the contracts are with major pharmaceutical companies who were existing customers, while the fourth is with a new customer focused on "high throughput drug discovery". Chief Executive Officer Martin Gouldstone says: "I am encouraged to see the commercial traction already being made on delivering our strategy, including our ability to expand the application of our ImmunoINSIGHTS platform into drug discovery as well as clinical trials. I have recently spent time discussing our strategy with some of our key stakeholders and have been pleased to see how well it has been received, also allowing us to recruit top talent to further accelerate our ability to deliver on it."

----------

Baron Oil PLC - London-based oil & gas exploration and appraisal company - Celebrates as its wholly-owned owned subsidiary, SundaGas Banda Unipessoal Lda, gets project classification from Autoridade Nacional do Petroleo for the Chuditch field. Sundagas is the operator of the TL-SO-19-16 production sharing contract, offshore Timor-Leste, while ANP is the Timor-Leste government regulator for oil and gas. The next step is the submission of a term of reference, including initial public consultations. Baron Oil adds that, regarding drilling, a Timorese drilling engineer has been recruited to join the SundaGas well operations team, and expressions of interest are being sought from in-country suppliers to provide services from the Timorese private sector. It also continues to evaluate all potential options for gas export from the Chuditch field in order to be able to fast track the concept selection processes.

----------

Arkle Resources PLC - Exploration company, with principal assets in Irish gold and zinc exploration licences - Says a drilling programme at Inishowen in County Donegal is due to begin this week. The drilling, which is a follow-up to work at the Meeneragh target, will test the main gold bearing outcrop. Four holes are planned in this phase from two drill pads drilling at minus 45 and minus 70 degrees. The focus of the programme will be on the main vein target discovered earlier. Chair John Teeling says: "It is good to get back on the ground again at Inishowen. This new round of drilling will test to see if we can trace the main vein along strike and at depth. We found high grade gold in the area and we now aim to expand this."

----------

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
12 Feb 2020 09:10

Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses

Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses

Read more
28 Jan 2020 13:52

Oncimmune Reports Study Results For Cancer Test Product

Oncimmune Reports Study Results For Cancer Test Product

Read more
22 Nov 2019 16:05

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Nov 2019 13:33

Oncimmune And Biodesix Complete US Agreement For Lung Cancer Test

Oncimmune And Biodesix Complete US Agreement For Lung Cancer Test

Read more
31 Oct 2019 11:38

Oncimmune Annual Loss Deepens On Costs But Makes Operational Progress

Oncimmune Annual Loss Deepens On Costs But Makes Operational Progress

Read more
25 Sep 2019 11:32

CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility

CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility

Read more
23 Sep 2019 16:08

Oncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks

Oncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks

Read more
20 Sep 2019 15:47

Oncimmune funded into 2021 with new EUR 8.5m facility

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has secured a credit facility of €8.5m (£7.5m) with IPF Management, it announced on Friday.

Read more
20 Sep 2019 14:04

Oncimmune Secures EUR8.5 Billion Debt For Products Commercialisation

(Alliance News) - Oncimmune Holdings PLC on Friday said it has secured a credit facility of EUR8.5 million with IPF Management SA.The immunodiagnostics company said it will immediately draw

Read more
9 Sep 2019 12:07

Oncimmune "Thrilled" With EarlyCDT Lung Cancer Test Trial Result

(Alliance News) - Oncimmune Holdings PLC on Monday announced positive results from a trial of its EarlyCDT Lung test to detect early stage lung cancer.Shares in Oncimmune were up 5.5% at in

Read more
15 Jul 2019 12:55

Oncimmune Further Expands EarlyCDT Lung Sales In Spain Through Vithas

(Alliance News) - Oncimmune Holdings PLC on Monday said Sabartech SL, its existing distributor in Spain and Portugal, has agreed with Vithas Group to sell EarlyCDT Lung as a screening test for of

Read more
28 Jun 2019 11:03

Oncimmune sells US operations to and partners with Biodesix

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has entered into an exclusive partnership agreement, it announced on Friday, which it said could "unlock the full potential" of its 'EarlyCDT Lung' product in the United States.

Read more
26 Jun 2019 10:58

Oncimmune confident of 'material profitable revenues'

(Sharecast News) - Immunodiagnostics firm Oncimmune told investors on Wednesday it was confident it could generate "material profitable revenues" on the back of several business developments.

Read more
4 Jun 2019 09:56

Oncimmune Holdings Reports Positive Lung Cancer Study Results

LONDON (Alliance News) - Oncimmune Holdings PLC on Tuesday reported positive top line results from its early cancer detection test in patients with lung cancer.Oncimmune Holdings shares at

Read more
15 May 2019 15:27

Oncimmune distributor gets approval for 'EarlyCDT-Lung' in Israel

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Wednesday that its distributor for Israel, Best Medical Opinion, has received regulatory approval for the sale of the 'EarlyCDT-Lung' product in Israel.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.